Skip to main content
Fig.3 | BMC Cancer

Fig.3

From: Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database

Fig.3

a Kaplan–Meier analyses of the effect chemotherapy on OS in original samples (P = 0.639, log-rank test); b Kaplan–Meier analyses of the effect chemotherapy on BCSM in original samples (P = 0.001, log-rank test); c Kaplan–Meier analyses of the effect chemotherapy on OS in matched samples (P = 0.962, log-rank test); d Kaplan–Meier analyses of the effect chemotherapy on BCSM in matched samples (P = 0.002, log-rank test)

Back to article page